Day-Supply of Opioid Rx Factor in Likelihood of Long-Term Use

This article originally appeared here.
Share this content:
Day-Supply of Opioid Rx Factor in Likelihood of Long-Term Use
Day-Supply of Opioid Rx Factor in Likelihood of Long-Term Use

WEDNESDAY, Aug. 23, 2017 (HealthDay News) -- The days supplied is far more important than the dosage level or even the type of pain being treated in risk of opioid use disorder following opioid prescription, according to a study published recently in The Journal of Pain.

Bradley Martin, Pharm.D., Ph.D., a pharmacist at the University of Arkansas for Medical Sciences in Little Rock, and colleagues examined 2006 to 2015 medical records for 1,353,902 patients who were prescribed opioids for the first time.

The overwhelming majority of patients discontinued opioid use, the researchers found. Patients were more likely to continue using the opioids if they were initially prescribed medications for a longer time.

"Comparing someone who has a one- or two-day supply of opioids with someone who has a week's supply, the risk of use doubles," Martin said in a university news release. "This is something clinicians can easily modify when they prescribe opioids." He and his team suggested prescribers use "the minimum effective opioid dose and duration to reduce unintended long-term use."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »